Integrated Supportive and Palliative Care for Critical Illness
(ProPACC Trial)
Trial Summary
What is the purpose of this trial?
The National Academy of Medicine and the National Institutes of Health have called for urgent action to improve the care delivered to the nearly 1,000,000 older Americans who die in intensive care units (ICUs) annually, or survive with substantial impairments. These patients often die with distressing symptoms and may receive more invasive, life-prolonging treatment than they would choose for themselves. Moreover, their family members acting as surrogate decision makers often experience lasting psychological distress from the ICU experience. The investigators will conduct a randomized trial among 500 patients and 750 surrogates and up to 150 clinicians to determine whether early integration of specialty palliative care with standard critical care can improve outcomes for critically ill older patients at high risk of death or severe functional impairments and their family members.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Early Integration of Specialty Palliative Care with Critical Care?
Research shows that integrating palliative care into intensive care units can help reduce stress for patients and families and improve end-of-life care. Additionally, early integration of palliative care in cancer treatment has been found to improve symptom control, quality of life, and even survival, suggesting potential benefits in critical care settings as well.12345
Is integrated supportive and palliative care safe for humans?
How is the treatment 'Early Integration of Specialty Palliative Care with Critical Care' different from other treatments for critical illness?
This treatment is unique because it combines critical care, which focuses on extending life, with palliative care, which emphasizes comfort and quality of life. By integrating these two approaches early, it aims to improve the overall care experience for critically ill patients and their families, addressing both medical and emotional needs.23578
Research Team
Douglas B White, MD, MAS
Principal Investigator
University of Pittsburgh
Yael Schenker, MD, MAS
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for older adults (60+) in the ICU with critical illnesses like coma after cardiac arrest, severe strokes, organ failures, or chronic conditions such as end-stage liver disease. They must have a high risk of death or severe disability and not be imminently dying, within a year post-organ transplant, non-English speaking, or without a surrogate decision maker.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Early integration of specialty palliative care with standard critical care for critically ill older patients
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Assessment of resource utilization and survival from hospital discharge through 6-month follow-up
Treatment Details
Interventions
- Early Integration of Specialty Palliative Care with Critical Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Massachusetts General Hospital
Collaborator
National Institute on Aging (NIA)
Collaborator